Status:

COMPLETED

Establishing Efficacy of an Inpatient Intervention and Phone App to Reduce Suicidal Risk

Lead Sponsor:

University of Texas Southwestern Medical Center

Collaborating Sponsors:

University of Pittsburgh

American Foundation for Suicide Prevention

Conditions:

Suicidal Ideation

Suicide, Attempted

Eligibility:

All Genders

12-17 years

Phase:

NA

Brief Summary

In this 2-site study, University of Texas Southwestern Medical Center (UTSW) and Western Psychiatric Institute and Clinic (WPIC), the investigators will conduct a randomized clinical trial (RCT) in 24...

Detailed Description

The investigators aim to randomize 240 adolescents psychiatrically hospitalized for suicidal ideation with a plan or a suicide attempt to one of four treatment arms: (1) ASAP + BRITE + TAU (treatment ...

Eligibility Criteria

Inclusion

  • Youth admitted to the inpatient unit at either site for a recent suicide attempt or significant suicidal ideation with a plan or intent.
  • The youth and parent are able to complete assessments in English, and the youth is able to complete therapy.

Exclusion

  • The youth currently exhibits psychosis.
  • The youth currently exhibits mania.
  • The youth is currently \<85% of their ideal body weight.
  • The youth is intellectually incapable of completing the study, e.g. has an intelligence quotient (IQ) \< 70.

Key Trial Info

Start Date :

April 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 15 2022

Estimated Enrollment :

241 Patients enrolled

Trial Details

Trial ID

NCT03825588

Start Date

April 1 2019

End Date

December 15 2022

Last Update

January 31 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213

2

University of Texas Southwestern Medical Center

Dallas, Texas, United States, 75390

Establishing Efficacy of an Inpatient Intervention and Phone App to Reduce Suicidal Risk | DecenTrialz